Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Total Current Liabilities (2016 - 2026)

Nutex Health (NUTX) has disclosed Total Current Liabilities for 17 consecutive years, with $184.4 million as the latest value for Q1 2026.

  • For Q1 2026, Total Current Liabilities fell 5.99% year-over-year to $184.4 million; the TTM value through Mar 2026 reached $184.4 million, down 5.99%, while the annual FY2025 figure was $157.9 million, 2.39% up from the prior year.
  • Total Current Liabilities hit $184.4 million in Q1 2026 for Nutex Health, up from $157.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $196.2 million in Q1 2025 and bottomed at $8.4 million in Q1 2022.
  • Average Total Current Liabilities over 5 years is $98.0 million, with a median of $67.3 million recorded in 2023.
  • Year-over-year, Total Current Liabilities surged 675.25% in 2022 and then dropped 5.99% in 2026.
  • Nutex Health's Total Current Liabilities stood at $54.9 million in 2022, then grew by 6.29% to $58.3 million in 2023, then surged by 164.48% to $154.2 million in 2024, then increased by 2.39% to $157.9 million in 2025, then rose by 16.8% to $184.4 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $184.4 million, $157.9 million, and $185.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.